EUVIMEDEUVIMED entdecken
Crossref

Multi-cohort validation: A comprehensive exploration of prognostic marker in clear cell renal cell carcinoma

Yifei Li, Congcong Fan, Yuhang Hu, Weizhi Zhang, Hang Li, Yining Wang, Ziqiang Xu

International Immunopharmacology · 2024

DOI: 10.1016/j.intimp.2024.112300 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2024. Verfasst von Yifei Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Zhejiang Key Laboratory of Intelligent Cancer Biomarker Discovery and Translation, The First Affiliated Hospital of Wenzhou Medical University, Wenzh…. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms, Biomarkers, Tumor. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 75 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Clear cell renal cell carcinoma (ccRCC) is the most common form of RCC. It is characterized by resistance to traditional radiotherapy and chemotherapy, as well as an unfavorable clinical prognosis. Although TYMP is implicated in the advancement of tumor progression, the role of TYMP in ccRCC is still not understood. Heightened TYMP expression was identified in ccRCC through database mining and confirmed in RCC cell lines. Indeed, TYMP knockdown impacted RCC cell proliferation, migration, and invasion in vitro. TYMP showed a positive correlation with clinicopathological parameters (histological grade, pathological stage). Moreover, patients with high TYMP expression were indicative of poor prognosis in TCGA-ccRCC and external cohorts. The results of single-cell analysis showed that the distribution of TYMP was predominantly observed in monocytes and macrophages. Furthermore, there is a significant association between TYMP and immune status. Methylation analysis further elucidated the relationship between TYMP expression and multiple methylation sites. Drug sensitivity analysis unveiled potential pharmaceutical options. Additionally, mutation analyses identified an association between TYMP and the ccRCC driver genes like BAP1 and ROS1. In summary, TYMP may serve as a reliable prognostic indicator for ccRCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Renal CellKidney NeoplasmsBiomarkers, TumorHumansPrognosisCell Line, TumorGene Expression Regulation, NeoplasticMaleCohort StudiesFemaleCell ProliferationDNA MethylationCell MovementMiddle Aged

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Zhejiang Key Laboratory of Intelligent Cancer Biomarker Discovery and Translation, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China.
  • Department of Urology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China.
  • Department of Urology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China. Electronic address: xuziqiang@wzhospital.cn.

Zitieren

APA

Li, Y., Fan, C., Hu, Y., Zhang, W., Li, H., Wang, Y., & Xu, Z. (2024). Multi-cohort validation: A comprehensive exploration of prognostic marker in clear cell renal cell carcinoma. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2024.112300

Vancouver

Li Y, Fan C, Hu Y, Zhang W, Li H, Wang Y, et al. Multi-cohort validation: A comprehensive exploration of prognostic marker in clear cell renal cell carcinoma. International Immunopharmacology. 2024. doi:10.1016/j.intimp.2024.112300

BibTeX
@article{Li2024,
  author = {Li, Yifei and Fan, Congcong and Hu, Yuhang and Zhang, Weizhi and Li, Hang and Wang, Yining and Xu, Ziqiang},
  title = {Multi-cohort validation: A comprehensive exploration of prognostic marker in clear cell renal cell carcinoma},
  journal = {International Immunopharmacology},
  year = {2024},
  doi = {10.1016/j.intimp.2024.112300}
}
Kostenlos starten →